Rapid Diagnostic Tests

Rapid Diagnostic Tests: The Basics - Speedy Sleuths

• Definition: Tests providing rapid results, often at or near the point of patient care.
• Principle: Typically detect microbial antigens, host antibodies, or microbial nucleic acids.
• Key Advantages:
  • Speed (results often <30 mins to 2 hours)
  • Ease of use (minimal training)
  • Minimal equipment needs
  • Point-of-care testing (POCT) suitability
• Limitations:
  • Generally lower sensitivity/specificity compared to culture or PCR.
  • Often qualitative (yes/no) or semi-quantitative.
  • Potential for false positives/negatives; results need clinical correlation.

⭐ Key advantages of RDTs include speed (results often in <30 mins to 2 hours), ease of use, and minimal equipment needs, making them ideal for resource-limited settings and point-of-care testing.

Rapid Diagnostic Tests: Immuno-RDTs - Antibody Avengers

• Immuno-RDTs: Detect microbial antigens (Ag) or host antibodies (Ab) swiftly.
• Lateral Flow Assays (LFAs): Most prevalent.
  • Principle: Capillary action transports sample; specific Ag-Ab binding with colored particles (e.g., gold) creates visible lines.
  • Strip: Sample pad → Conjugate pad (labeled Abs) → Nitrocellulose membrane (Test & Control lines) → Absorbent pad.
  • Examples: Pregnancy (hCG), Malaria (HRP2, pLDH), Strep A, Dengue (NS1, IgM/IgG), HIV.

⭐ Most Lateral Flow Assays (LFAs) (e.g., pregnancy tests, malaria RDTs, Strep A) incorporate a control line to validate test strip integrity and proper sample flow; absence of control line invalidates the test.

Rapid Diagnostic Tests: Molecular & Other RDTs - Gene Genies & Quick Chems

• Molecular RDTs (Gene Genies): Detect pathogen-specific DNA/RNA.
  • Nucleic Acid Amplification Tests (NAATs):
    • PCR (Polymerase Chain Reaction): Amplifies target DNA.
    • RT-PCR: For RNA targets (e.g., HIV, HCV, SARS-CoV-2).
    • LAMP (Loop-mediated Isothermal Amplification): Rapid, isothermal, field use.
  • Microarrays: Simultaneous detection of multiple genes/pathogens.
  • NGS (Next-Generation Sequencing): Comprehensive analysis, outbreak investigation.
• Other RDTs (Quick Chems):
  • MALDI-TOF MS: Rapid ID of bacteria/fungi via protein profiling (minutes).
  • Rapid Biochemical Tests: (e.g., API strips) for enzyme activity, metabolic profile.

⭐ CBNAAT (Cartridge-Based Nucleic Acid Amplification Test) like GeneXpert for MTB can detect M. tuberculosis and rifampicin resistance simultaneously from sputum within 2 hours, revolutionizing TB diagnosis.

Rapid Diagnostic Tests: RDTs in Action - Disease Detectives

• Immunochromatographic assays detecting specific antigens/antibodies.
• Point-of-care; results in ~15-30 min.
• Malaria:
  • HRP2 for P. falciparum.
  • pLDH for Pan-Plasmodium/species-specific.
• Dengue:
  • NS1 Ag (early, 1-7 days).
  • IgM/IgG Ab (later).
• HIV:
  • Antibody detection (screening); confirmation needed.
• Tuberculosis (TB):
  • Molecular: CBNAAT for M.tb & RIF resistance.
• Strep Throat:
  • RADTs for Group A Strep (GAS) antigen.
• COVID-19:
  • Antigen tests (active infection).
  • Antibody tests (past exposure).

⭐ For Dengue diagnosis, NS1 antigen RDTs are useful in the early febrile phase (first 1-7 days), while IgM/IgG antibody tests become positive later in infection.

High‑Yield Points - ⚡ Biggest Takeaways

• RDTs provide rapid results (minutes-hours), vital for prompt clinical decisions.
• Most utilize antigen-antibody reactions (e.g., immunochromatography, ELISA, agglutination).
• Key examples: Strep A, malaria, influenza, COVID-19 antigen tests.
• Molecular RDTs (e.g., GeneXpert, CBNAAT) offer high accuracy for specific targets like MTB.
• Many are Point-of-Care Tests (POCT), enabling decentralized testing.
• Sensitivity may be lower than culture; specificity is generally good.
• Primarily for pathogen detection, not antimicrobial susceptibility testing (AST).